Literature DB >> 30852150

Microstructural changes of normal-appearing white matter in Vascular Parkinsonism.

Maria Salsone1, Maria Eugenia Caligiuri2, Virginia Vescio3, Gennarina Arabia4, Andrea Cherubini1, Giuseppe Nicoletti1, Maurizio Morelli4, Andrea Quattrone4, Basilio Vescio5, Rita Nisticò1, Fabiana Novellino1, Giuseppe Lucio Cascini6, Umberto Sabatini3, Michaela Montilla7, Ivan Rektor7, Aldo Quattrone8.   

Abstract

OBJECTIVE: Several evidences demonstrated the role of white matter (WM) lesions in the pathogenesis of Vascular Parkinsonism (VP), a clinical entity characterized by parkinsonism, postural instability, marked gait difficulty and poor response to levodopa. However, the involvement of normal appearing white matter (NAWM) in VP still remains unknown. This study aimed to investigate the microstructural integrity of NAWM in VP compared to Parkinson's disease (PD) and controls using neuroimaging approach.
METHODS: Magnetic resonance imaging data were acquired from 50 participants (15 VP, 20 PD and 15 controls). Diffusion tensor imaging (DTI) and Tract-based spatial statistics (TBSS) were performed to assess microstructural NAWM changes. In order to evaluate the relationship between specific fiber tract involvement and clinical picture, diffusion alterations were correlated with clinical features.
RESULTS: Compared to PD patients and controls, significantly reduced fractional anisotropy (FA) and increased mean diffusivity (MD) and radial diffusivity (RD) in NAWM of corpus callosum, internal and external capsule, and corona radiata were present in VP. By contrast, DTI metrics were normal in NAWM-PD and controls. A significant correlation was found between FA and MD of anterior third of corpus callosum and clinical variables (postural instability, freezing-of-gait and symmetry of parkinsonism).
CONCLUSIONS: This study improves the knowledge on WM pathology in VP, as our results demonstrate that NAWM damage occurs in VP, but not in PD nor in controls. NAWM damage might relate to clinical picture and suggest that non-clearly-visible WM alterations may contribute to the physiopathology of this vascular disease.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diffusion tensor imaging; Normal-appearing white matter; TBSS; Vascular parkinsonism

Mesh:

Year:  2019        PMID: 30852150     DOI: 10.1016/j.parkreldis.2019.02.046

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Semi-automated assessment of the principal diffusion direction in the corpus callosum: differentiation of idiopathic normal pressure hydrocephalus from neurodegenerative diseases.

Authors:  Maria Eugenia Caligiuri; Andrea Quattrone; Alessandro Mechelli; Domenico La Torre; Aldo Quattrone
Journal:  J Neurol       Date:  2021-08-24       Impact factor: 4.849

Review 2.  Neuroimaging in Vascular Parkinsonism.

Authors:  Karen K Y Ma; Shi Lin; Vincent C T Mok
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

3.  Microstructural damage of the cortico-striatal and thalamo-cortical fibers in Fabry disease: a diffusion MRI tractometry study.

Authors:  Sirio Cocozza; Simona Schiavi; Giuseppe Pontillo; Matteo Battocchio; Eleonora Riccio; Simona Caccavallo; Camilla Russo; Teodolinda Di Risi; Antonio Pisani; Alessandro Daducci; Arturo Brunetti
Journal:  Neuroradiology       Date:  2020-07-22       Impact factor: 2.804

4.  Pedunculopontine Nucleus Dysconnectivity Correlates With Gait Impairment in Parkinson's Disease: An Exploratory Study.

Authors:  Stephen Joza; Richard Camicioli; W R Wayne Martin; Marguerite Wieler; Myrlene Gee; Fang Ba
Journal:  Front Aging Neurosci       Date:  2022-07-08       Impact factor: 5.702

Review 5.  Role of Diffusion Tensor Imaging in the Diagnosis of Traumatic Axonal Injury in Individual Patients with a Concussion or Mild Traumatic Brain Injury: A Mini-Review.

Authors:  Sung-Ho Jang; Min-Jye Cho
Journal:  Diagnostics (Basel)       Date:  2022-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.